[HTML][HTML] Targeting microglial α-synuclein/TLRs/NF-kappaB/NLRP3 inflammasome axis in Parkinson's disease

Y Li, Y Xia, S Yin, F Wan, J Hu, L Kou, Y Sun… - Frontiers in …, 2021 - frontiersin.org
According to emerging studies, the excessive activation of microglia and the subsequent
release of pro-inflammatory cytokines play important roles in the pathogenesis and …

Development of multifunctional molecules as potential therapeutic candidates for Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis in the …

MG Savelieff, G Nam, J Kang, HJ Lee, M Lee… - Chemical …, 2018 - ACS Publications
Neurodegenerative diseases pose a substantial socioeconomic burden on society.
Unfortunately, the aging world population and lack of effective cures foreshadow a negative …

[HTML][HTML] Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes

H Scheiblich, C Dansokho, D Mercan, SV Schmidt… - Cell, 2021 - cell.com
Microglia are the CNS resident immune cells that react to misfolded proteins through pattern
recognition receptor ligation and activation of inflammatory pathways. Here, we studied how …

[HTML][HTML] RhoA signaling in neurodegenerative diseases

SI Schmidt, M Blaabjerg, K Freude, M Meyer - Cells, 2022 - mdpi.com
Ras homolog gene family member A (RhoA) is a small GTPase of the Rho family involved in
regulating multiple signal transduction pathways that influence a diverse range of cellular …

Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons

J Pujols, S Peña-Díaz, DF Lázaro… - Proceedings of the …, 2018 - National Acad Sciences
Parkinson's disease (PD) is characterized by a progressive loss of dopaminergic neurons, a
process that current therapeutic approaches cannot prevent. In PD, the typical pathological …

[HTML][HTML] ROCK inhibition in models of neurodegeneration and its potential for clinical translation

JC Koch, L Tatenhorst, AE Roser, KA Saal… - Pharmacology & …, 2018 - Elsevier
Neurodegenerative disorders like Parkinson's disease, Alzheimer's disease, or amyotrophic
lateral sclerosis are affecting a rapidly increasing population worldwide. While common …

Molecular basis of small-molecule binding to α-synuclein

P Robustelli, A Ibanez-de-Opakua… - Journal of the …, 2022 - ACS Publications
Intrinsically disordered proteins (IDPs) are implicated in many human diseases. They have
generally not been amenable to conventional structure-based drug design, however …

Intrinsically disordered proteins and biomolecular condensates as drug targets

M Biesaga, M Frigolé-Vivas, X Salvatella - Current Opinion in Chemical …, 2021 - Elsevier
Intrinsically disordered domains represent attractive therapeutic targets because they play
key roles in cancer, as well as in neurodegenerative and infectious diseases. They are …

[HTML][HTML] ROCK inhibitors upregulate the neuroprotective Parkin-mediated mitophagy pathway

N Moskal, V Riccio, M Bashkurov, R Taddese… - Nature …, 2020 - nature.com
The accumulation of damaged mitochondria causes the death of dopaminergic neurons.
The Parkin-mediated mitophagy pathway functions to remove these mitochondria from cells …

Targeting α‐synuclein aggregation and its role in mitochondrial dysfunction in Parkinson's disease

ME Haque, M Akther, S Azam, IS Kim… - British Journal of …, 2022 - Wiley Online Library
Lewy bodies that contain aggregated α‐synuclein in dopamine neurons are the main culprit
for neurodegeneration in Parkinson's disease. However, mitochondrial dysfunction has a …